Myasthenia gravis and atracurium. A case report.
The degree, duration of and recovery from neuromuscular blockade induced by atracurium in a patient with myasthenia gravis were monitored and recorded using the evoked compound muscle action potentials (EMG). The anaesthetic and perioperative management were simplified by the use of this technique. The significance of the behaviour of atracurium is discussed.
D000200:Action Potentials / Q000187:drug effects; D000328:Adult; D001279:Atracurium; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007546:Isoquinolines / Q000494:pharmacology*; D009119:Muscle Contraction / Q000187:drug effects; D009157:Myasthenia Gravis / Q000503:physiopathology*; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000503:physiopathology*; D009435:Synaptic Transmission / Q000187:drug effects*; D013997:Time Factors
D007546:Isoquinolines; D009466:Neuromuscular Blocking Agents; D001279:Atracurium